Browsing by Author "Castro-Rodriguez, J.A."
Now showing 1 - 7 of 7
Results Per Page
Sort Options
- ItemChest physiotherapy in paediatric patients hospitalised with community-acquired pneumonia: A randomised clinical trial(2012) Lukrafka, J.L.; Fuchs, S.C.; Fischer, G.B.; Flores, J.A.; Fachel, J.M.; Castro-Rodriguez, J.A.Background Chest physiotherapy has been used to treat children hospitalised with pneumonia with no clear scientific evidence to support a beneficial effect. The objective of the current study was to evaluate the efficacy of chest physiotherapy as an adjuvant treatment in children hospitalised with acute community-acquired pneumonia.
- ItemErratum: Anticholinergics in the treatment of children and adults with acute asthma: A systematic review with meta-analysis (Thorax (2005) 60, (740-746))(2006) Rodrigo, G.J.; Castro-Rodriguez, J.A.
- ItemErratum: Asthma attributable to atopy: Does it depend on the allergen supply? (Pediatric Allergy and Immunology (2007) 18, (181-187))(2007) Garcia-Marcos, L.; Garcia-Hernández, G.; Morales Suarez-Varela, M.; Batlles Garrido, J.; Castro-Rodriguez, J.A.
- ItemErratum: Principal findings of systematic reviews of acute asthma treatment in childhood (Journal of Asthma (2016) 53:3 (339))(2016) Castro-Rodriguez, J.A.; Rodrigo, G.J.; Rodríguez-Martínez, C.A.
- ItemInfantile and preschool asthma(2012) Castro-Rodriguez, J.A.; Rodriguez-Martinez, C.E.; Custovic, A.In infants and preschool children the symptoms suggestive of asthma (e.g. wheeze) may be a clinical expression of a number of diseases with different aetiologies. If this is true, then it is unlikely that these different diseases would respond to the same treatment. Consequently, implementation of a management strategy which is effective for each individual patient is challenging, and controversies remain with respect to which patients should be given anti-asthma treatment, and when the treatment should be started and for how long. Whilst acknowledging these uncertainties, practicing physicians may use the Asthma Predictive Index (API) as a guide in clinical practice to identify young children with recurrent wheezing who are at risk of the subsequent development of persistent asthma, and who may benefit from preventative anti-asthma medication. We acknowledge that a number of questions on the most appropriate management strategy remain unanswered, including which type of medication is the best for individual patients (e.g. short-acting beta-agonist versus inhaled corticosteroid (ICS) versus leukotriene receptor antagonist (LTRA)), dose (high versus low) and schedule (regular versus as needed).